Development and validation of the sarcopenia composite index: A comprehensive approach for assessing sarcopenia in the ageing population.
10.47102/annals-acadmedsg.2024272
- Author:
Hsiu-Wen KUO
1
;
Chih-Dao CHEN
1
;
Amy Ming-Fang YEN
2
;
Chenyi CHEN
3
;
Yang-Teng FAN
4
Author Information
1. Department of Family Medicine, Far Eastern Memorial Hospital, New Taipei City, Taiwan.
2. School of Oral Hygiene, College of Oral Medicine, Taipei Medical University, Taipei, Taiwan.
3. Graduate Institute of Injury Prevention and Control, Taipei Medical University, Taipei, Taiwan.
4. Graduate Institute of Medicine, Yuan Ze University, Taoyuan, Taiwan.
- Publication Type:Validation Study
- Keywords:
composite index;
early diagnosis;
elderly;
risk factors;
sarcopenia
- MeSH:
Humans;
Sarcopenia/physiopathology*;
Male;
Aged;
Female;
Retrospective Studies;
Hand Strength;
Taiwan/epidemiology*;
ROC Curve;
Aged, 80 and over;
Risk Factors;
Walking Speed;
Geriatric Assessment/methods*;
Prevalence;
Muscle, Skeletal;
Middle Aged
- From:Annals of the Academy of Medicine, Singapore
2025;54(2):101-112
- CountrySingapore
- Language:English
-
Abstract:
INTRODUCTION:The diagnosis of sarcopenia relies on key indicators such as handgrip strength, walking speed and muscle mass. Developing a composite index that integrates these measures could enhance clinical evaluation in older adults. This study aimed to standardise and combine these metrics to establish a z score for the sarcopenia composite index (ZoSCI) tailored for the ageing population. Additionally, we explore the risk factors associated with ZoSCI to provide insights into early prevention and intervention strategies.
METHOD:This retrospective study analysed data between January 2017 and December 2021 from an elderly health programme in Taiwan, applying the Asian Working Group for Sarcopenia criteria to assess sarcopenia. ZoSCI was developed by standardising handgrip strength, walking speed and muscle mass into z scores and integrating them into a composite index. Receiver operating characteristic (ROC) curve analysis was used to determine optimal cut-off values, and multiple regression analysis identified factors influencing ZoSCI.
RESULTS:Among the 5047 participants, the prevalence of sarcopenia was 3.7%, lower than the reported global prevalence of 3.9-15.4%. ROC curve analysis established optimal cut-off points for distinguishing sarcopenia in ZoSCI: -1.85 (sensitivity 0.91, specificity 0.88) for males and -1.97 (sensitivity 0.93, specificity 0.88) for females. Factors associated with lower ZoSCI included advanced age, lower education levels, reduced exercise frequency, lower body mass index and creatinine levels.
CONCLUSION:This study introduces ZoSCI, a new compo-site quantitative indicator for identifying sarcopenia in older adults. The findings highlight specific risk factors that can inform early intervention. Future studies should validate ZoSCI globally, with international collaborations to ensure broader applicability.
